Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Mr. William Fink R.Ph.

President, Managed Care Pharmacy Consultants, Inc

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

William Fink, RPh, is the President of Managed Care Pharmacy Consultants in Tucson, Arizona. He has been active in managed care pharmacy for over 25 years. Mr. Fink's expertise includes managing pharmacy and clinical programs for HMOs (including Medicare and Medicaid) and self insured employer groups. He evaluates new biotech and orphan drug pharmaceuticals for formulary inclusion. Mr. Fink developed the Rx Accord software program to provide patient pharmacy and laboratory data to hospital emergency rooms and in-patient facilities. In the field of Health Information Exchange (HIE), he has contracted with the state of Arizona to develop the ability of physicians, hospital EDs, and urgent care centers to access patient pharmacy and laboratory data through a secure website. Mr. Fink also has a wide knowledge of the profit structure, price trends, and other trends that will drive PBM performance over the next few years. (This is me - Update Profile)


Employment History

1992 - Unspecified
President, Managed Care Pharmacy Consultants, Inc

GLG NewsSM Analyses by William Fink(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Dangers of Methadone Usage

August 28, 2008

Dr. Mark Yergin testifies to Congress | www.nytimes.com

Doctors must be educated on the correct use of Methadone if unnecessary deaths are to be avoided.

Trends for Chronic Kidney Disease (CKD)

June 26, 2008

Resource Article: “Chronic Kidney Disease Prevalence Increases, Awareness Remains Low,” Drug Benefit Trends (vol. 20, no. 5, May 2008) | jama.ama-assn.org

There will be an increased use of costly diaylsis, especially among those people 70 years or older.  One would think that there would be a greater awareness of a disease consting $31 billion dollars a year.  However, this does not seem to be the case.

Government Cuts in Funding for DXA in Physicians' Offices May Lead to Difficulties for Rural Patients

May 6, 2008

DXA Reimbursement Reductions: Implications for Quality Osteoporosis Care, Marjorie Luckey, MD and Roberta Biegel (Washington, DC: National Osteoporosis Foundation, Winter 2005) | osteoporosisblogger.com

It is well known that millions of people in the US suffer from osteoporosis which leads directly to debilitating fractures.   Early diagnosis of osteoporosis and low bone mass will help prevent chronic pain and loss of independence.  Once diagnosed, treatment is readily available and effective.  DXA of the hip and spine (central DXA) is the imaging procedure recommended for this diagnosis and monitoring for the effectiveness of treatment.  However, without legistative action, patient access to the central DXA may be compromised.

Leading institutions connect with William Fink through GLG

GLG Live Meetings with William Fink(?)

William Fink has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare